Screening of non-phage group II Staphylococcus aureus strains for antagonistic substances revealed one particular strain, S. aureus D91, to excrete a substance with a wide spectrum of activity; both Gram-positive and Gram-negative bacteria were susceptible. The staphylococcin-like substance D91 produced by this strain was partially purified by column chromatography on Sephadex G-50, DEAE-cellulose, Phenyl Sepharose CL-4B and Sephadex G-200. A molecular weight of 76000 was estimated by gel filtration. The activity was heat sensitive but was not affected by hydrolytic enzymes except for pronase. The protein character of substance D91 was confirmed by gel electrophoresis and subsequent staining with Coomassie blue. The action exerted on sensitive bacteria was bacteriostatic rather than bactericidal. Biosynthesis of DNA, RNA, protein and polysaccharides were inhibited simultaneously in both Escherichia coli and Staphylococcus aureus. Active transport of glutamic acid was stopped in both S. cohnii and E. coli, whereas glucose uptake was inhibited in E. coli only. The substance induced a slow efflux of 86Rb+ from proloaded cells of S. cohnii and E. coli. The antagonistic activity of S. aureus D91 was eliminated by ethidium bromide at a rate of 47.6% suggesting that plasmids may be involved in its production.
DajaniA. S., WannamakerL. W.1973a; Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria. Journal of Bacteriology 114:738–742
DajaniA. S., WannamakerL. W.1973b; In vitro and in vivo studies on a phage type 7 i staphylococcal bacteriocin. In Staphylococci and Staphylococcal Infection pp. 413–421JeljaszewiczJ. Edited by Basel: S. Karger;
DajaniA. S., TaubeZ.1974; Plasmid mediated production of staphylococcin in bacteriophage type 71 Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 5:594–598
DajaniA. S., GrayE. D.1970; Effect of bactericidal substance from Staphylococcus aureus on group A streptococci. I. Biochemical alterations. Infection and Immunity 1:485–490
HaleE. M., HinsdillR. D.1975; Biological activity of staphylococcin 462: bacteriocin from Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 7:74–81
KopeckyA. L., CopelandD. P., LuskJ. E.1975; Viability of Escherichia coli treated with colicin K. Proceedings of the National Academy of Sciences of the United States of America 72:4631–4634
RogolskyM., WileyB. B.1977; Production and properties of staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis. Infection and Immunity 15:726–732
ScheinS. J., KaganB. L., FinkelsteinA.1978; Colicin K acts by forming voltage dependent channels in phospholipid bilayer membranes. Nature; London: 276159–163
WarrenR., RogolskyM., WileyB. B., GlasgowL. A.1974; Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus. Journal of Bacteriology 118:980–985
WeerkampA., GeertsW., VogelsG. D.1977; Conditional killing effect of staphylococcin and repair of sublethal injury in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 12:314–321